Infection Control Market Size, Share, Growth Analysis, By Product (Sterilization Products, Cleaning and Disinfection Products), By Application (Surgical Instruments, Endoscopes), By Distribution Channel (Direct Tender, Retail Sales), By End User (Hospitals, Clinics), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35A2623 | Region: Global | Published Date: December, 2025
Pages: 165 |Tables: 65 |Figures: 75

To request a free sample copy of this report, please complete the form below.

Our Clients

Schineder Electric

KSIA - Korea Semiconductor Industry Association

Hitachi Astemo Limited

Samsung Electronics

Halvo holdings

NTT corporation

AGC Inc

Siemens AG

Unilever

Merck Pharmaceuticals

Atlas Copco

Hologic - Medical Technology company

Novartis

Henkel

Reckitt

Schineder Electric

KSIA - Korea Semiconductor Industry Association

Hitachi Astemo Limited

Samsung Electronics

Halvo holdings

NTT corporation

AGC Inc

Siemens AG

Unilever

Merck Pharmaceuticals

Atlas Copco

Hologic - Medical Technology company

Novartis

Henkel

Reckitt

FAQs

Global Infection Control Market size was valued at USD 48.17 Billion in 2024 and is poised to grow from USD 51.2 Billion in 2025 to USD 83.48 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026–2033).

Giant companies such as Advanced Sterilization Products, STERUS Corporation, and Cantel Medical Corporation, which command most market share, use collaboration techniques by rivalry. Their focus was on competitive techniques such as mergers & acquisitions, new product development programs, and regional expansion. For instance, 3M recently introduced a four-hour rapid readout biological indicator for steam sterilization loads. It is designed to give results within four hours but is intended primarily for vaporized hydrogen peroxide sterilization. It was introduced to further expand the company's product line. '3M Company (USA)', 'Ecolab Inc. (USA) ', 'Getinge AB (Sweden) ', 'STERIS plc (Ireland) ', 'Fortive Corporation (USA) ', 'Cardinal Health, Inc. (USA) ', 'Medline Industries, LP (USA) ', 'Paul Hartmann AG (Germany) ', 'Becton, Dickinson and Company (BD) (USA) ', 'Johnson & Johnson (USA) ', 'MMM Group (Germany) ', 'Belimed AG (Switzerland) ', 'Envista Holdings Corporation (USA) ', 'SC Johnson Professional (USA) ', 'Reckitt Benckiser Group plc (UK) ', 'Gojo Industries, Inc. (USA) ', 'Diversey Holdings, Ltd. (USA)'

The rising rate of healthcare-associated infections is one of the major market drivers in infection control. Through the awareness of the need for proper infection prevention strategies, the current increased cases of healthcare associated infections remind these providers that infections affect millions of patients every year. Such apprehension has increased costs in infection control practices and consumables such as PPEs, disinfectants, and sterilizing equipment. Health care organizations have approached infection control measures in a holistic manner with the emphasis put on safety of patients and quality of care provided. This has increased demand for innovative solutions to minimize risks of infections and to ensure better overall health care delivery.

Use of High-Tech Advancement: Currently, in the infection control market, high-tech advancement, such as automation and digitalization, is being increasingly used to enhance the measures of infection prevention. Healthcare institutions are increasingly adopting smart technology for more efficient and effective infection control processes. Instances include automatic disinfection systems and real-time monitoring solutions. These advancements do not just facilitate the process but also give intelligence where compliance can be tracked and areas of need for improvement can be identified. It is expected that the embedding of technology in infection control plans with advancement in technology will bring massive change in patient safety and operational efficiency in healthcare settings.

North America led global infection control market by leveraging over 30% in revenue. Through the various strategic partnerships, the major players in the industry have forged to expand their product lines and expand their infection control capabilities, it has achieved this significant market share. Furthermore, the resulting leading portion taken by North America is mainly due to the increased attempts of the established corporations throughout this area for expansion. For instance, Advanced Sterilization Products introduced the STERRAD 100NX System with ALLClear to the US and is now looking to further penetrate into Europe, Africa, and the Middle East.

To request a free sample copy of this report, please complete the form below.

Our Clients

FAQs

What is the global market size of Infection Control Market?

Who are the key vendors in the Infection Control Market?

What is the key driver of Infection Control Market?

What is the key market trend for Infection Control Market?

Which region accounted for the largest share in Infection Control Market?

$5,300